{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:20:03Z","timestamp":1783066803575,"version":"3.54.6"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Consorcio Centro de Investigaci\u00f3n Biom\u00e9dica en Red (CIBER) en Bioingenier\u00eda"},{"name":"Biomateriales y Nanomedicina","award":["CB19\/01\/00012"],"award-info":[{"award-number":["CB19\/01\/00012"]}]},{"name":"CIBER en Enfermedades Infecciosas","award":["CB21\/13\/00051"],"award-info":[{"award-number":["CB21\/13\/00051"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic migraine is a debilitating disorder characterized by central sensitization and impaired habituation. Although OnabotulinumtoxinA (OnabotA) is an established preventive treatment, its precise mechanism of action and predictors of therapeutic response remain elusive. In this prospective cohort study, we integrated clinical parameters with algometric assessments, a recognized tool for evaluating peripheral sensitization, to develop machine learning-based predictive models to forecast migraine treatment response and effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seventy-six patients underwent comprehensive clinical evaluations and pressure pain threshold measurements. Key clinical and algometric variables were identified using a feature selection algorithm and incorporated into linear regression models for continuous outcomes (reductions in migraine days, headache days, symptomatic medication use, and triptan use) and an ordinal logistic regression model for categorical treatment response considering percentage of decrease in headache days [3 classes: low (&amp;lt;50%), moderate (50%-75%), and high (&amp;gt;75%) responders].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The linear regression models yielded significant correlations, exemplified by a reduction in migraine days (\u03c1\u2009=\u20090.762, RMSE\u2009=\u20095.70) and symptomatic medication days (\u03c1\u2009=\u20090.503, RMSE\u2009=\u20097.84). Similarly, the ordinal logistic regression model achieved an overall accuracy of 56.6% to predict treatment effectiveness (\u03ba\u2009=\u20090.334 for 3 classes), as well as 71.1%, 64.5%, and 77.6% accuracies to predict high, moderate, and low OnabotA response. Notably, incorporating algometric data significantly enhanced predictive performance compared to models based solely on clinical variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings support the potential of combined clinical and algometric evaluation as a practical biomarker for optimizing OnabotA therapy in chronic migraine, warranting further validation in larger, multicenter studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/pm\/pnag060","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:37:41Z","timestamp":1776944261000},"page":"753-762","source":"Crossref","is-referenced-by-count":0,"title":["Algometric assessment of sensitization and habituation as predictive markers for OnabotulinumtoxinA response in chronic migraine"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7882-7890","authenticated-orcid":false,"given":"Javier","family":"Gomez-Pilar","sequence":"first","affiliation":[{"name":"Biomedical Engineering Group, University of Valladolid , Valladolid,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN) , Valladolid,","place":["Spain"]},{"name":"Valladolid Health Research Institute (IBioVALL) , Valladolid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5898-2006","authenticated-orcid":false,"given":"Fernando","family":"Vaquerizo-Villar","sequence":"additional","affiliation":[{"name":"Biomedical Engineering Group, University of Valladolid , Valladolid,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN) , Valladolid,","place":["Spain"]},{"name":"Valladolid Health Research Institute (IBioVALL) , Valladolid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3132-1064","authenticated-orcid":false,"given":"David","family":"Garc\u00eda-Azor\u00edn","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario R\u00edo Hortega , Valladolid,","place":["Spain"]},{"name":"Department of Medicine, University of Valladolid , Valladolid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Sierra-Menc\u00eda","sequence":"additional","affiliation":[{"name":"Valladolid Health Research Institute (IBioVALL) , Valladolid,","place":["Spain"]},{"name":"Headache Unit, Department of Neurology, Hospital Cl\u00ednico Universitario de Valladolid , Valladolid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7493-6002","authenticated-orcid":false,"given":"\u00c1ngel Luis","family":"Guerrero-Peral","sequence":"additional","affiliation":[{"name":"Valladolid Health Research Institute (IBioVALL) , Valladolid,","place":["Spain"]},{"name":"Department of Medicine, University of Valladolid , Valladolid,","place":["Spain"]},{"name":"Headache Unit, Department of Neurology, Hospital Cl\u00ednico Universitario de Valladolid , Valladolid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9915-2570","authenticated-orcid":false,"given":"Roberto","family":"Hornero","sequence":"additional","affiliation":[{"name":"Biomedical Engineering Group, University of Valladolid , Valladolid,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN) , Valladolid,","place":["Spain"]},{"name":"Valladolid Health Research Institute (IBioVALL) , Valladolid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"key":"2026070303521593700_pnag060-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ane.12229","article-title":"Neurological disorders in the Global Burden of Disease 2010 study","volume":"129","author":"Stovner","year":"2014","journal-title":"Acta Neurol Scand Suppl"},{"key":"2026070303521593700_pnag060-B2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","article-title":"Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache J Head Face Pain"},{"key":"2026070303521593700_pnag060-B3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1212\/01.CON.0000418640.07405.31","article-title":"Migraine diagnosis and pathophysiology","volume":"18","author":"Ward","year":"2012","journal-title":"Contin Lifelong Learn Neurol"},{"key":"2026070303521593700_pnag060-B4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(88)90277-1","article-title":"Pericranial muscle tenderness and pressure-pain threshold in the temporal region during common migraine","volume":"35","author":"Jensen","year":"1988","journal-title":"Pain"},{"key":"2026070303521593700_pnag060-B5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N","article-title":"An association between migraine and cutaneous allodynia","volume":"47","author":"Burstein","year":"2000","journal-title":"Ann Neurol"},{"key":"2026070303521593700_pnag060-B6","doi-asserted-by":"crossref","first-page":"770397","DOI":"10.3389\/fpain.2022.770397","article-title":"Algometer assessment of pressure pain threshold after Onabotulinumtoxin-A and physical therapy treatments in patients with chronic migraine: an observational study","volume":"3","author":"Deodato","year":"2022","journal-title":"Front Pain Res"},{"key":"2026070303521593700_pnag060-B7","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/pm\/pnw056","article-title":"Women with chronic and episodic migraine exhibit similar widespread pressure pain sensitivity","volume":"17","author":"Palacios-Ce\u00f1a","year":"2016","journal-title":"Pain Med"},{"key":"2026070303521593700_pnag060-B8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/head.12984","article-title":"Differences in topographical pressure pain sensitivity maps of the scalp between patients with migraine and healthy controls","volume":"57","author":"Bar\u00f3n","year":"2017","journal-title":"Headache"},{"key":"2026070303521593700_pnag060-B9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10194-008-0061-7","article-title":"Evidence of persistent central sensitization in chronic headaches: a multi-method study","volume":"9","author":"Filatova","year":"2008","journal-title":"J Headache Pain"},{"key":"2026070303521593700_pnag060-B10","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/0333102417729114","article-title":"Roller pressure algometry as a new tool for assessing dynamic pressure sensitivity in migraine","volume":"38","author":"Guerrero-Peral","year":"2018","journal-title":"Cephalalgia"},{"key":"2026070303521593700_pnag060-B11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1468-2982.2008.01831.x","article-title":"Pressure pain sensitivity mapping of the temporalis muscle revealed bilateral pressure hyperalgesia in patients with strictly unilateral migraine","volume":"29","author":"Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2009","journal-title":"Cephalalgia"},{"key":"2026070303521593700_pnag060-B12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40265-018-0894-6","article-title":"OnabotulinumtoxinA: a review in the prevention of chronic migraine","volume":"78","author":"Frampton","year":"2018","journal-title":"Drugs"},{"key":"2026070303521593700_pnag060-B13","doi-asserted-by":"crossref","first-page":"e32600","DOI":"10.1097\/MD.0000000000032600","article-title":"Treatment of chronic migraine with Botox (OnabotulinumtoxinA): development, insights, and impact","volume":"102","author":"Turkel","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"2026070303521593700_pnag060-B14","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jpain.2009.04.017","article-title":"Bilateral widespread mechanical pain sensitivity in women with myofascial temporomandibular disorder: evidence of impairment in central nociceptive processing","volume":"10","author":"Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2009","journal-title":"J Pain"},{"key":"2026070303521593700_pnag060-B15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"2026070303521593700_pnag060-B16","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1526-4610.2010.01766.x","article-title":"Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program","volume":"50","author":"Blumenfeld","year":"2010","journal-title":"Headache J Head Face Pain"},{"key":"2026070303521593700_pnag060-B17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache J Head Face Pain"},{"key":"2026070303521593700_pnag060-B18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1526-4610.2011.01990.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program","volume":"51","author":"Aurora","year":"2011","journal-title":"Headache J Head Face Pain"},{"key":"2026070303521593700_pnag060-B19","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/head.14806","article-title":"Advancing toward precision migraine treatment: predicting responses to preventive medications with machine learning models based on patient and migraine features","volume":"64","author":"Chiang","year":"2024","journal-title":"Headache J Head Face Pain"},{"key":"2026070303521593700_pnag060-B20","doi-asserted-by":"crossref","first-page":"E 01043","DOI":"10.1016\/j.heliyon.2018.e01043","article-title":"Prediction of patient\u2019s response to OnabotulinumtoxinA treatment for migraine","volume":"5","author":"Parrales Bravo","year":"2019","journal-title":"Heliyon"},{"key":"2026070303521593700_pnag060-B21","first-page":"1","volume-title":"2024 International Conference on Electrical, Computer and Energy Technologies (ICECET), Sidney, Australia","author":"Parrales-Bravo","year":"2024"},{"key":"2026070303521593700_pnag060-B22","first-page":"629","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013"},{"key":"2026070303521593700_pnag060-B23","first-page":"1","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018"},{"key":"2026070303521593700_pnag060-B24","doi-asserted-by":"crossref","first-page":"208.e1","DOI":"10.1016\/j.medcli.2024.02.006","article-title":"Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine t","volume":"163","author":"Belv\u00eds","year":"2024","journal-title":"Med Cl\u00ednica"},{"key":"2026070303521593700_pnag060-B25","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/0333102418758283","article-title":"Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults","volume":"38","author":"Tassorelli","year":"2018","journal-title":"Cephalalgia"},{"key":"2026070303521593700_pnag060-B26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"2026070303521593700_pnag060-B27","first-page":"1205","article-title":"Efficient feature selection via analysis of relevance and redundancy","volume":"5","author":"Yu","year":"2004","journal-title":"J Mach Learn Res"},{"key":"2026070303521593700_pnag060-B28","volume-title":"Data Mining: Practical Machine Learning Tools and Techniques","author":"Hall","year":"2011"},{"key":"2026070303521593700_pnag060-B29","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.3390\/jcm10132898","article-title":"OnabotulinumtoxinA in migraine: a review of the literature and factors associated with efficacy","volume":"10","author":"Ray","year":"2021","journal-title":"JCM"},{"key":"2026070303521593700_pnag060-B30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/0333102418825346","article-title":"Predictors of allodynia in persons with migraine: results from the Migraine in America Symptoms and Treatment (MAST) study","volume":"39","author":"Dodick","year":"2019","journal-title":"Cephalalgia"},{"key":"2026070303521593700_pnag060-B31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s10194-023-01651-9","article-title":"Cutaneous allodynia as predictor for treatment response in chronic migraine: a cohort study","volume":"24","author":"Pijpers","year":"2023","journal-title":"J Headache Pain"},{"key":"2026070303521593700_pnag060-B32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/AJP.0b013e31826b130f","article-title":"Allodynia in migraine","volume":"29","author":"Misra","year":"2013","journal-title":"Clin J Pain"},{"key":"2026070303521593700_pnag060-B33","doi-asserted-by":"crossref","first-page":"107357","DOI":"10.1016\/j.clineuro.2022.107357","article-title":"Cutaneous allodynia and thermal thresholds in chronic migraine: the effect of OnabotulinumtoxinA","volume":"220","author":"Ozarslan","year":"2022","journal-title":"Clin Neurol Neurosurg"},{"key":"2026070303521593700_pnag060-B34","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1177\/03331024221084217","article-title":"Localized and widespread pressure pain hypersensitivity in patients with episodic or chronic migraine: a systematic review and meta-analysis","volume":"42","author":"Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2022","journal-title":"Cephalalgia"},{"key":"2026070303521593700_pnag060-B35","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1177\/03331024211010305","article-title":"Efficacy of erenumab in chronic migraine patients with and without ictal allodynia","volume":"41","author":"Lipton","year":"2021","journal-title":"Cephalalgia"},{"key":"2026070303521593700_pnag060-B36","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1177\/0333102417720217","article-title":"Migraine triggers and habituation of visual evoked potentials","volume":"38","author":"Lisicki","year":"2018","journal-title":"Cephalalgia"},{"key":"2026070303521593700_pnag060-B37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10194-008-0095-x","article-title":"Cortical inhibition and habituation to evoked potentials: relevance for pathophysiology of migraine","volume":"10","author":"Brighina","year":"2009","journal-title":"J Headache Pain"},{"key":"2026070303521593700_pnag060-B38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nlm.2008.07.006","article-title":"Habituation and migraine","volume":"92","author":"Coppola","year":"2009","journal-title":"Neurobiol Learn Mem"},{"key":"2026070303521593700_pnag060-B39","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1046\/j.1526-4610.43.7s.3.x","article-title":"Evidence for antinociceptive activity of botulinum toxin type A in pain management","volume":"43","author":"Aoki","year":"2003","journal-title":"Headache J Head Face Pain"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnag060\/68162224\/pnag060.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/27\/7\/753\/68162224\/pnag060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/27\/7\/753\/68162224\/pnag060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:53:07Z","timestamp":1783065187000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/27\/7\/753\/8662839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4,26]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnag060","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,4,26]]}}}